U.S. Markets closed

Seres Therapeutics: 1Q Earnings Snapshot

CAMBRIDGE, Mass. (AP) _ Seres Therapeutics Inc. (MCRB) on Wednesday reported a loss of $27.9 million in its first quarter.

The Cambridge, Massachusetts-based company said it had a loss of 69 cents per share.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 75 cents per share.

The drug developer posted revenue of $4 million in the period.

Seres Therapeutics shares have declined 18 percent since the beginning of the year. The stock has dropped 14 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MCRB at https://www.zacks.com/ap/MCRB